Japanese Major Dispensing Pharmacy Chain Ain Pharmaciez Listed On Tokyo Stock Exchange
This article was originally published in PharmAsia News
Executive Summary
Japan's major dispensing drug store chain Ain Pharmaciez will be listed on the second section of the Tokyo Stock Exchange April 2. The Sapporo, Hokkaido-based company owns 362 dispensing pharmacies and 44 drug stores nationwide as of January. Ain achieved ¥106 billion in sales and ¥4.3 billion in profit for fiscal year 2008. Last August, the company signed a partnership agreement with Seven and I holdings to expand its healthcare business in Japan. (Click here for more - Japanese language
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.